Vanguard Group’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.67M | Buy |
1,450,367
+16,536
| +1% | +$87.5K | ﹤0.01% | 3042 |
|
|
2025
Q1 | $11.7M | Buy |
1,433,831
+10,392
| +0.7% | +$84.6K | ﹤0.01% | 2763 |
|
|
2024
Q4 | $18.2M | Buy |
1,423,439
+5,767
| +0.4% | +$73.8K | ﹤0.01% | 2628 |
|
|
2024
Q3 | $15.2M | Buy |
1,417,672
+21,971
| +2% | +$236K | ﹤0.01% | 2739 |
|
|
2024
Q2 | $11.1M | Sell |
1,395,701
-12,435
| -0.9% | -$98.5K | ﹤0.01% | 2857 |
|
|
2024
Q1 | $22.6M | Buy |
1,408,136
+15,356
| +1% | +$246K | ﹤0.01% | 2541 |
|
|
2023
Q4 | $19.1M | Buy |
1,392,780
+32,084
| +2% | +$440K | ﹤0.01% | 2615 |
|
|
2023
Q3 | $19.9M | Buy |
1,360,696
+11,062
| +0.8% | +$162K | ﹤0.01% | 2556 |
|
|
2023
Q2 | $23M | Buy |
1,349,634
+143,802
| +12% | +$2.45M | ﹤0.01% | 2535 |
|
|
2023
Q1 | $16.8M | Buy |
1,205,832
+57,506
| +5% | +$803K | ﹤0.01% | 2666 |
|
|
2022
Q4 | $7.58M | Buy |
1,148,326
+571
| +0% | +$3.77K | ﹤0.01% | 3085 |
|
|
2022
Q3 | $6.05M | Hold |
1,147,755
| – | – | ﹤0.01% | 3220 |
|
|
2022
Q2 | $5.45M | Sell |
1,147,755
-129,222
| -10% | -$614K | ﹤0.01% | 3337 |
|
|
2022
Q1 | $10.8M | Buy |
1,276,977
+6,467
| +0.5% | +$54.8K | ﹤0.01% | 3108 |
|
|
2021
Q4 | $15.2M | Buy |
1,270,510
+8,562
| +0.7% | +$103K | ﹤0.01% | 2977 |
|
|
2021
Q3 | $22.4M | Sell |
1,261,948
-33,543
| -3% | -$594K | ﹤0.01% | 2807 |
|
|
2021
Q2 | $26.6M | Buy |
1,295,491
+231,520
| +22% | +$4.75M | ﹤0.01% | 2695 |
|
|
2021
Q1 | $21.1M | Buy |
1,063,971
+721,346
| +211% | +$14.3M | ﹤0.01% | 2760 |
|
|
2020
Q4 | $6.37M | Buy |
342,625
+57,714
| +20% | +$1.07M | ﹤0.01% | 3240 |
|
|
2020
Q3 | $7.17M | Buy |
+284,911
| New | +$7.17M | ﹤0.01% | 2968 |
|